Our areas of focus include early stage drug discovery services, preclinical services, clinical services as well as enabling technologies in all these areas.

Our current portfolio consists of the following companies:


Molecular Response enables pharmaceutical partners to realize efficiencies in drug development through use of clinically proven molecular markers.

Learn More


BioAtla is a protein therapeutic service business whose capabilities span a wide range of protein therapeutic development activities and pre-clinical testing.

Learn More


Femta Pharmaceuticals is a business focused on the development of therapeutic monoclonal antibodies for the treatment of various disease states.

Learn More


Formex provides innovative solutions to our client's drug development challenges that span formulation development through clinical and commercial cGMP manufacturing.

Learn More

Biotech Investment Group is a privately held investment company with significant fund commitments from its founders.

Biotech Investment group (B.i.G) founded in 2006, is a provider of growth equity capital to emerging healthcare services companies. Our mission is to partner with outstanding entrepreneurs to build long lasting companies and deliver services which address significant unmet healthcare needs.